Research Article
Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer
Table 3
Patient characteristics in the conventional and hypo-RT treatment groups.
| | Level | Con-RT, n (%) | Hypo-RT, n (%) | |
| n | | 57 (39.86) | 86 (60.14) | | Age | <65 | 27 (47.4) | 34 (39.5) | 0.450 | ≥65 | 30 (52.6) | 52 (60.5) |
| Gender | Female | 4 (7.0) | 9 (10.5) | 0.685 | Male | 53 (93.0) | 77 (89.5) |
| Tumor stage | IIIA | 37 (64.9) | 47 (54.7) | 0.295 | IIIB | 20 (35.1) | 39 (45.3) |
| PS | 0 | 29 (50.9) | 50 (58.1) | 0.494 | 1 | 28 (49.1) | 36 (41.9) |
| Pathology | Adenocarcinoma | 18 (31.6) | 35 (40.7) | 0.353 | Squamous cell carcinoma | 39 (68.4) | 51 (59.3) |
| Chemotherapy modality | Concurrent | 22 (38.6) | 36 (41.9) | 0.830 | Sequential | 35 (61.4) | 50 (58.1) |
| PET-CT planning | Yes | 24 (42.1) | 39 (45.3) | 0.702 | No | 33 (57.9) | 47 (54.7) |
| PTV (cc), median [IQR] | | 121.5 [69.0, 190.5] | 114.0 [67.5, 178.1] | 0.759 |
|
|
Hypo-RT: hypofractionated RT; Con-RT: conventional RT; PS: performance status; PTV: planning target volume; IQR: interquartile range.
|